This Month in The Journal  by Bungartz, Kathryn D. & Williamson, Robin E.
EDITORS’ CORNER
This Month in The Journal
Kathryn D. Bungartz1 and Robin E. Williamson2Using the Common to Find the Rare
Li et al., page 728; Zawistowski et al., page 604
As the number of studies evaluating an association
between common variants and a phenotype has increased,
it has become clear that common variants aren’t respon-
sible for the majority of heritability in most cases. This
has turned attention to searching for effects of rare vari-
ants. But, what are the best ways study rare variants? In
this issue, Li and colleagues and Zawistowski and
colleagues each present methods that contribute to the
identification of rare variants that are associated with
disease susceptibility. The methods share the goal of iden-
tifying disease alleles that have a minor allele frequency
of < 5%, and they both can use genome-wide association
study (GWAS) data to study these rare variants. The
thought is that although SNP panels are usually used to
study common variants in GWAS, they can also be used
to study low-frequency alleles if careful haplotyping is
used or if imputation from external sequencing data,
such as that from the 1000 Genomes Project, is incorpo-
rated. In the Li et al. manuscript, the authors focus on
using haplotyping to assess rare variants in GWAS data
and then demonstrate how imputation using sequencing
data can add to their findings. Zawistowski et al. present
a method with the goal of being able to handle the uncer-
tainties involved with using low-coverage sequencing data
and imputed data and similarly conclude that sequencing
data can be used to impute rare variants from GWAS data.
Both groups demonstrate the utility of their approaches by
reevaluating previously published data.
How Can One Little Deletion Cause
So Much Trouble?
Moreno-De-Luca et al., page 618
Identifying variants associated with disease not only
contributes to the knowledge of which genes are likely to
be involved in certain biological pathways but also can
suggest links between pathologies when the same variant
is found to be associated with more than one phenotype.
Several association studies have found commonalities
among the features that are found at an increased
frequency in both patients with autism spectrum disorder
(ASD) and patients with neurodevelopmental or psychi-
atric disorders such as schizophrenia. In this issue, Moreno
De Luca and colleagues look closely at a recurrent deletion1Science Editor, AJHG; 2Deputy Editor, AJHG
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The Americanon 17q12. Genomic abnormalities of this locus have been
identified previously in patients with renal disease, dia-
betes, and epilepsy. In addition, deletion carriers have
been reported to have intellectual disability or ASD.
When the authors examine their first data set of patients
who were referred for intellectual disability or ASD, they
also identify a high frequency of 17q12 deletion carriers.
The authors also identify patients with schizophrenia
who carry the deletion. Because the authors find the dele-
tion in their patient populations but not in any controls,
they suggest that the deletion is highly penetrant but
that it has variable expressivity, on the basis of the wide
range of phenotypes that have been observed in carriers.
The deletion is a relatively common genomic abnormality,
and the full characterization of the phenotypes that it can
cause will assist in care and diagnosis of carriers.
Mutations in FLVCR1 Cause PCARP
Rajadhyaksha et al., page 643
PCARP is the name given to a syndrome characterized by
posterior column ataxia and retinitis pigmentosa. Patients
affected by PCARP suffer a progressive decline in visual
function and proprioception, the ability to sense where
body parts are in relation to the rest of the body. The onset
of clinical features occurs in early childhood, some patients
being diagnosed with RP before their one-year birthday
and with ataxia by the time they are ten. Using data
from three PCARP families, Rajadhyaksha and colleagues
are able to link the syndrome to a region on 1q, but as
often can be the case, when candidate genes in the linkage
region are sequenced, no obvious etiologic mutations are
identified. The authors then resequence the whole linkage
region in members of one of their families and report
a mutation in FLVCR1 that encodes a heme-transporter
protein. Two different mutations segregate with PCARP
in the other two families. Each of the mutations affects
a residue in a transmembrane domain of the channel
protein. Previous functional work has supported that
FLVCR1 is critical for erythropoiesis, and knockout mice
present with features of Diamond-Blackfan syndrome.
Here, the authors demonstrate that Flcvr1 is highly
expressed in the retina and posterior column of the spinal
cord and suggest that a disruption in heme transport due
to the PCARP-associated missense mutations might lead
to a decrease in neuroprotective effects and an increase
in apoptosis in these tissues.Genetics. All rights reserved.
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Rare CNVs in an All-Too-Common Condition
Glessner et al., page 661
Obesity is a huge health risk with an incidence that is
increasing throughout the world. This trend in children
presents a serious public health concern as the majority
of obese children grow to become obese adults. Obesity is
a category of body mass index (BMI), which is calculated
by dividing a person’s squared height (in cm) by their
weight (in kg). Averages depend on age, sex, and ethnicity,
but in general, a BMI of 25 kg/ m2 is the high end of
normal. People having a body mass index (BMI) greater
than 30 kg/m2 are considered to be obese. This means
that their bodies have accumulated a degree of excess fat
that may have dire health effects. Obesity has been associ-
ated with increased risk of several different diseases,
including type 2 diabetes, heart disease, cancer, and others.
Although obesity can be effectively treated with diet and
exercise, research is showing a small genetic contribution
to this condition. In addition to several SNPs being associ-
ated with BMI and obesity, deletions on chromosome
16p11.2 have been associated with severe early-onset
obesity and developmental delay. Here, Glessner and
colleagues examine a cohort of children presenting with
common obesity. They find a significantly higher inci-
dence of copy-number variants (CNVs) in the obese chil-
dren compared to lean controls. The products of several
genes affected by the identified CNVs are highlighted in
this study as being potential players in human BMI and
obesity. With increased knowledge of the risk factors asso-
ciated with childhood obesity comes increased hope for
curbing this disturbing trend.576 The American Journal of Human Genetics 87, 575–576, NovembLanguage Impairment OutFOXed
Hamdan et al., page 671
Language impairment describes communication disabil-
ities that can take many forms. From difficulty distinguish-
ing different sounds to inability to coordinate the muscles
required for speech, language impairment can have an
impact on the quality of daily life. It can be isolated or
part of a syndrome. Language impairment often accom-
panies intellectual disability (ID), cerebral palsy, and
autism spectrum disorders (ASD), as well as other develop-
mental disabilities. Although language impairment may
have many underlying causes, genetics are sure to play
a prominent role. Verbal dyspraxia is a specific type of
language impairment in which the affected individual
has difficulty planning and executing verbalizations.
Mutations in FOXP2 have been associated with verbal
dyspraxia. FOXP2 transcribes forkhead box protein P2,
a transcription factor involved in the regulation of several
developmental processes. FOXP1 is the closest relative of
FOXP2, and the two proteins interact to repress the tran-
scription of target genes. However, the association between
FOXP1 mutations and language impairment has been
elusive. Here, rather than looking directly at language
impairment, Hamdan and colleagues investigate the role
of FOXP1 disruption in associated syndromes, including
ID and ASD. In addition to identifying a de novo deletion
in a patient with ID and autistic features, this group iden-
tifies a de novo FOXP1 nonsense mutation in another
autistic patient with ID. Both patients show language
impairment, confirming the suspicion that both FOXP1
and FOXP2 are important for language development.er 12, 2010
